This inventor holds 5 USPTO granted patents. Top assignees: Takeda Chemical Industries, Inc., Takeda Pharmaceutical Company Limited. Active years: 1998-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sakai, JP (1998 - 2005)
- Osaka, JP (1999 - 2011)
Company Filing History:


Years Active: 1998-2011
Title: Innovations of Tatsumi Matsumoto
Introduction
Tatsumi Matsumoto is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical science, particularly in the development of therapeutic agents for respiratory diseases and inflammatory conditions. With a total of five patents to his name, Matsumoto's work reflects a commitment to advancing healthcare solutions.
Latest Patents
Matsumoto's latest patents include a preventive and therapeutic remedy for respiratory diseases. This invention aims to provide a compound that inhibits the activity of specific proteins associated with respiratory issues. Additionally, he has developed furoisoquinoline derivatives, which demonstrate an excellent phosphodiesterase IV-inhibiting effect. These compounds are useful in treating various inflammatory diseases, including bronchial asthma and chronic obstructive pulmonary disease (COPD).
Career Highlights
Throughout his career, Matsumoto has worked with prominent companies such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development.
Collaborations
Matsumoto has collaborated with esteemed colleagues, including Yasuko Ashida and Akio Miyake. These partnerships have fostered innovation and have been instrumental in the success of his projects.
Conclusion
Tatsumi Matsumoto's contributions to medical science through his patents and collaborations highlight his dedication to improving health outcomes. His innovative work continues to influence the field and offers hope for effective treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile